Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amarin Corporation PLC stock logo
AMRN
Amarin
$14.45
+0.6%
$15.06
$12.96
$20.90
$302.60M0.880,302 shs88,758 shs
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$3.02
-4.6%
$2.96
$1.66
$4.54
$297.24M2.12.10 million shs699,984 shs
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.56
-0.1%
$4.25
$1.04
$5.81
$294.35M0.55943,017 shs379,906 shs
Lifevantage Corporation stock logo
LFVN
Lifevantage
$6.21
+0.1%
$6.74
$3.90
$15.00
$78.31M0.73320,740 shs88,721 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amarin Corporation PLC stock logo
AMRN
Amarin
-2.24%-7.05%-5.71%-5.46%-10.75%
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
0.00%-15.73%+26.40%-6.23%+10.88%
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
-6.56%-12.10%-11.88%-37.65%+220.72%
Lifevantage Corporation stock logo
LFVN
Lifevantage
+0.16%-0.64%-31.49%+42.53%-49.92%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amarin Corporation PLC stock logo
AMRN
Amarin
$14.45
+0.6%
$15.06
$12.96
$20.90
$302.60M0.880,302 shs88,758 shs
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$3.02
-4.6%
$2.96
$1.66
$4.54
$297.24M2.12.10 million shs699,984 shs
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.56
-0.1%
$4.25
$1.04
$5.81
$294.35M0.55943,017 shs379,906 shs
Lifevantage Corporation stock logo
LFVN
Lifevantage
$6.21
+0.1%
$6.74
$3.90
$15.00
$78.31M0.73320,740 shs88,721 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amarin Corporation PLC stock logo
AMRN
Amarin
-2.24%-7.05%-5.71%-5.46%-10.75%
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
0.00%-15.73%+26.40%-6.23%+10.88%
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
-6.56%-12.10%-11.88%-37.65%+220.72%
Lifevantage Corporation stock logo
LFVN
Lifevantage
+0.16%-0.64%-31.49%+42.53%-49.92%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amarin Corporation PLC stock logo
AMRN
Amarin
2.50
Moderate BuyN/AN/A
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
2.57
Moderate Buy$5.4079.10% Upside
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
2.82
Moderate Buy$10.77202.93% Upside
Lifevantage Corporation stock logo
LFVN
Lifevantage
2.00
Hold$5.00-19.42% Downside

Current Analyst Ratings Breakdown

Latest LFVN, EDIT, IRD, and AMRN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/13/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
DowngradeHoldStrong Sell
7/6/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
Reiterated RatingBuy$13.00
7/6/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
Reiterated RatingBuy$12.00
6/23/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
Initiated CoverageOutperform$10.00
6/23/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
Initiated CoverageModerate Buy$10.00
6/18/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
Boost Price TargetBuy$11.00 ➝ $13.00
6/17/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
UpgradeStrong-Buy
6/17/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
Reiterated RatingBuy$8.00
6/16/2026
Amarin Corporation PLC stock logo
AMRN
Amarin
UpgradeHoldStrong-Buy
6/16/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
Reiterated RatingBuy$12.00
6/15/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
Reiterated RatingMarket Outperform$11.00
(Data available from 7/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amarin Corporation PLC stock logo
AMRN
Amarin
$213.65M1.42$0.35 per share40.72$22.07 per share0.65
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$38.69M7.63N/AN/A$0.28 per share10.77
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$11.98M24.49N/AN/A$0.22 per share16.16
Lifevantage Corporation stock logo
LFVN
Lifevantage
$228.53M0.34$1.10 per share5.63$2.75 per share2.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amarin Corporation PLC stock logo
AMRN
Amarin
-$38.80M-$0.65N/AN/AN/A-15.51%-2.99%-2.07%7/29/2026 (Estimated)
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
-$160.06M-$1.23N/AN/AN/A-281.59%-677.39%-58.25%8/11/2026 (Estimated)
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
-$49.59M-$1.33N/AN/AN/A-892.36%-338.88%-191.21%8/12/2026 (Estimated)
Lifevantage Corporation stock logo
LFVN
Lifevantage
$9.81M$0.4513.799.55N/A2.94%23.89%12.47%9/3/2026 (Estimated)

Latest LFVN, EDIT, IRD, and AMRN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
-$0.15N/AN/AN/A$2.64 millionN/A
8/11/2026Q2 2026
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
-$0.30N/AN/AN/A$2.85 millionN/A
7/29/2026Q2 2026
Amarin Corporation PLC stock logo
AMRN
Amarin
-$0.01N/AN/AN/A$44.55 millionN/A
5/12/2026Q1 2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
-$0.16-$0.75-$0.59-$0.75$2.93 million$2.16 million
5/6/2026Q3 2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.16$0.12-$0.04$0.11$47.77 million$43.72 million
5/5/2026Q1 2026
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
-$0.30-$0.26+$0.04-$0.26$6.37 million$2.83 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Amarin Corporation PLC stock logo
AMRN
Amarin
N/AN/AN/AN/AN/A
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
N/AN/AN/AN/AN/A
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
N/AN/AN/AN/AN/A
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.203.22%N/A44.44%3 Years

Latest LFVN, EDIT, IRD, and AMRN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/27/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
quarterly$0.052.12%6/1/20266/1/20266/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amarin Corporation PLC stock logo
AMRN
Amarin
N/A
3.48
2.46
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
N/A
3.22
3.22
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
N/A
7.13
7.13
Lifevantage Corporation stock logo
LFVN
Lifevantage
N/A
1.96
1.04

Institutional Ownership

CompanyInstitutional Ownership
Amarin Corporation PLC stock logo
AMRN
Amarin
22.25%
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
71.90%
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
14.97%
Lifevantage Corporation stock logo
LFVN
Lifevantage
35.32%

Insider Ownership

CompanyInsider Ownership
Amarin Corporation PLC stock logo
AMRN
Amarin
4.21%
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
3.10%
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
11.70%
Lifevantage Corporation stock logo
LFVN
Lifevantage
21.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amarin Corporation PLC stock logo
AMRN
Amarin
36020.97 million20.09 millionOptionable
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
23097.91 million94.87 millionOptionable
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
1482.57 million72.91 millionN/A
Lifevantage Corporation stock logo
LFVN
Lifevantage
26012.62 million9.85 millionOptionable

Recent News About These Companies

Lifevantage (LFVN) Stock Forecast & Price Target
LFVN Share News Today
Lifevantage Stock Price History
LifeVantage (LFVN) Q3 2026 Earnings Transcript
LifeVantage Declares Quarterly Dividend
LifeVantage Q3 2026 earnings preview

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amarin stock logo

Amarin NASDAQ:AMRN

$14.45 +0.08 (+0.56%)
As of 01:40 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Editas Medicine stock logo

Editas Medicine NASDAQ:EDIT

$3.02 -0.15 (-4.59%)
As of 01:41 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 BRILLIANCE trial for Leber Congenital Amaurosis; and reni-cel, a clinical development gene-edited medicine to treat sickle cell disease and transfusion-dependent beta-thalassemia. In addition, the company is developing alpha-beta T cells for solid and liquid tumors; and gamma delta T cell therapies to treat cancer. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; strategic alliance and option agreement with Allergan Pharmaceuticals International Limited. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Opus Genetics stock logo

Opus Genetics NASDAQ:IRD

$3.56 -0.01 (-0.14%)
As of 01:41 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.

Lifevantage stock logo

Lifevantage NASDAQ:LFVN

$6.20 +0.01 (+0.08%)
As of 01:40 PM Eastern
This is a fair market value price provided by Massive. Learn more.

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.